Target intelligence / Profile preview

Long intergenic non-protein coding RNA 861 (LINC00861)

Target
LINC00861
Molecular classification
Long non-coding RNA (lncRNA), Intergenic lncRNA
01

Overview

Long intergenic non-protein coding RNA 861 (LINC00861) is a long non-coding RNA found in humans, transcribed but not translated into protein, and located on chromosome 8[5][7][8]. LINC00861 plays a functional role as a competing endogenous RNA (ceRNA), modulating gene expression by sponging specific microRNAs such as miR-513b-5p[2]. This activity regulates critical cellular pathways including the PTEN/AKT/mTOR axis and affects processes such as cell proliferation, migration, invasion, and the epithelial-mesenchymal transition (EMT)[2]. LINC00861 has demonstrated tumor-suppressive properties in certain cancers, with low expression linked to more aggressive disease and worse prognosis, while high expression within immune cells of lung tumors has been associated with improved patient outcomes and stronger cytotoxic immune activity[2][4]. At present, LINC00861 is not classified as a direct therapeutic target (e.g., receptor, enzyme) and no drugs are known to interact with it directly, but it may serve as a promising prognostic biomarker for patient stratification in oncology[2][4][8].

Other names
LINC00861ENSG00000245164100130231Various historical GeneCards IDs (e.g., GC08M126935, GC08M126936, etc.)
02

Biological functions

Competing endogenous RNA (ceRNA) activityRegulation of cell proliferationRegulation of cell migration and invasionRegulation of epithelial-mesenchymal transition (EMT)Regulation of PTEN/AKT/mTOR pathwayPossible modulation of immune response
03

Disease associations

Cancer (e.g., cervical cancer, ovarian cancer, hepatocellular carcinoma, breast cancer)Biomarker for prognosis in lung cancer and possibly other diseases
04

Biomarkers

Low expression associated with poor prognosis in ovarian and cervical cancerHigh expression associated with favorable immune-related prognosis in lung cancer

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 861 (LINC00861).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 861 (LINC00861).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call